MedWatch

Demant turns up outlook after better-than-expected sales

The sales of hearing devices, particularly in Europe, causes Demant to adjust its outlook.

Photo: Jens Dresling

At this point in time, the growth in revenue for the latter half of 2020 looks better than the Danish hearing aid firm Demant had expected, for which reason the firm upgrades its outlook to 12-14 percent, compared with the former 8-13 percent.

Aside from the revenue, Demant is also guiding for higher income in the second half-year, according to an announcement from the firm.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs